Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Anemia

Free Subscription Articles published in J Pediatr Hematol Oncol Retrieve available abstracts of 74 articles: HTML format

Single Articles

August 2025
1. ALALI M, Tat K, Overholt K
   Hepatitis-Associated Aplastic Anemia in Children: Unraveling Clinical Mysteries in a Single-Center Case Series-More Questions Than Answers!
   J Pediatr Hematol Oncol. 2025 Aug 14. doi: 10.1097/MPH.0000000000003105.
   PubMed     Abstract available
   
   
   
2. LEE AC
   Autologous Cord Blood Transplantation for Idiopathic Severe Aplastic Anemia.
   J Pediatr Hematol Oncol. 2025 Aug 11. doi: 10.1097/MPH.0000000000003106.
   PubMed     Abstract available
   
   
   
3. DURAN BC, Ay Y, Imancli H, Akcay G, et al
   The Effect of Iron Deficiency Anemia and Serum Ferritin Deficiency on Cognitive Functions in Children 1 to 5 Years Old.
   J Pediatr Hematol Oncol. 2025 Aug 4. doi: 10.1097/MPH.0000000000003090.
   PubMed     Abstract available
   
   
   
4. RAHIM MQ, Goubeaux DL, Ebenroth C, Voulgaridou A, et al
   Capturing Fertility: A Qualitative Exploration of Retention of a Fertility Consult in Sickle Cell Disease.
   J Pediatr Hematol Oncol. 2025;47:297-302.
   PubMed     Abstract available
   
   
   
5. NGUYEN TM, Sadiq S, Peterson JM, Wang LK, et al
   Concurrent Case of Glucose-6-Phosphate Deficiency and Dehydrated Hereditary Stomatocytosis in a 4-Month-old Boy.
   J Pediatr Hematol Oncol. 2025;47:e278-e281.
   PubMed     Abstract available
   
   
   July 2025
6. ELGEHINY A, Quraishi MZ, Yadav A, Srivaths LV, et al
   Variability in the Recommendations for Management of Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease: Review of Institutional Algorithms of Pediatric Hospitals Across the United States.
   J Pediatr Hematol Oncol. 2025;47:e155-e160.
   PubMed     Abstract available
   
   
   June 2025
7. PRASUN P, Suarez JR, Watkin KJ
   Cobalamin E Disease: An Ultrarare Treatable Cause of Hemolytic Anemia in Infancy.
   J Pediatr Hematol Oncol. 2025 Jun 23. doi: 10.1097/MPH.0000000000003072.
   PubMed    
   
   
   May 2025
8. DANG MP, Rubbab B, Kwon JK, Noland D, et al
   Successful Use of Granulocyte Transfusion Therapy as a Bridge to Hematopoietic Stem Cell Transplant in a Child With Aplastic Anemia and Refractory Perirectal Abscess.
   J Pediatr Hematol Oncol. 2025;47:204-207.
   PubMed     Abstract available
   
   
   
9. RUSHING M, Horiuchi S, Kayle M, Reeves SL, et al
   Patterns and Predictors of Hydroxyurea Use Among Californians Living With Sickle Cell Disease.
   J Pediatr Hematol Oncol. 2025;47:169-176.
   PubMed     Abstract available
   
   
   April 2025
10. OREN H
    In Reply: Time to Resolution of Severe Anemia in Young Children With Iron Deficiency.
    J Pediatr Hematol Oncol. 2025 Apr 21. doi: 10.1097/MPH.0000000000003030.
    PubMed    
    
    
    
11. TAMURA S, Ishida H, Tomoyasu C, Yano M, et al
    Idiopathic Pulmonary Hemosiderosis Complicated by Direct Antiglobulin Test-negative Autoimmune Hemolytic Anemia.
    J Pediatr Hematol Oncol. 2025 Apr 7. doi: 10.1097/MPH.0000000000003032.
    PubMed    
    
    
    
12. SEFIKA ILKNUR KK, Medine KA, Huseyin K, Eda Turgut U, et al
    Tracing a Rare Genetic Disease: Familial Congenital CD59 Deficiency and Carrier Cases Identified Through Village Screening.
    J Pediatr Hematol Oncol. 2025;47:109-114.
    PubMed     Abstract available
    
    
    
13. LANTZ M, Dolatshahi L
    Hereditary Pyropoikilocytosis as a Modifier of Sickle Cell Disease Severity.
    J Pediatr Hematol Oncol. 2025;47:128-130.
    PubMed     Abstract available
    
    
    March 2025
14. 
    Severe Unexplained Iron Deficiency Anemia in Children: High Yield of Upper Gastrointestinal Endoscopy Regardless of Gastrointestinal Symptoms: Erratum.
    J Pediatr Hematol Oncol. 2025;47:85.
    PubMed    
    
    
    
15. ERNO J, Noisette L, Bergmann S, Diaz C, et al
    Implementation of a Low-risk Algorithm for Outpatient Management of Febrile Pediatric Patients With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2025;47:80-85.
    PubMed     Abstract available
    
    
    
16. OZ A, Ozdemir AM, Ceylaner S, Aydin S, et al
    Rare Etiology of Isolated Macrocytosis: Adenosine Kinase Deficiency With a Novel Mutation.
    J Pediatr Hematol Oncol. 2025;47:e96-e98.
    PubMed     Abstract available
    
    
    
17. NIRMAL G, Pendharkar D, Gupta N, Raj A, et al
    Knowledge, Attitude, and Practice of Patients Suffering From Sickle Cell Disease in an Endemic Zone.
    J Pediatr Hematol Oncol. 2025;47:86-90.
    PubMed     Abstract available
    
    
    February 2025
18. DCUNHA NJ, Kwan OA, Sen S, Diaz-Medina GE, et al
    Ethosuximide-associated Aplastic Anemia Likely Due to Drug-induced Lupus Erythematosus: A Case Report With Immunologic Insights.
    J Pediatr Hematol Oncol. 2025 Feb 21. doi: 10.1097/MPH.0000000000003011.
    PubMed     Abstract available
    
    
    
19. BOUMEGHAR K, Buchbinder N, Metot C, Bera E, et al
    Hemolytic Anemia With Acanthocytes During Alectinib Treatment of Anaplastic T-Cell Lymphoma: A Case Report and Literature Review.
    J Pediatr Hematol Oncol. 2025 Feb 17. doi: 10.1097/MPH.0000000000003003.
    PubMed     Abstract available
    
    
    January 2025
20. LOUIE E, Tang A, Patel A, Srinivasan R, et al
    Improving Sickle Cell Patient Appointment Compliance in a Hospital-based Pediatric Ophthalmology Clinic.
    J Pediatr Hematol Oncol. 2025;47:e44-e47.
    PubMed     Abstract available
    
    
    
21. PATEL R, Reisert H, Keymakh M, Drakou E, et al
    Management of Spontaneous Epidural Hematoma in the Setting of Vaso-occlusive Crisis Among Pediatric Patients With Sickle Cell Disease: A Case Series and Scoping Literature Review.
    J Pediatr Hematol Oncol. 2025;47:38-46.
    PubMed     Abstract available
    
    
    
22. HUANG L, Miller D, Hajjar F
    Case Report of Dinutuximab-induced Atypical Hemolytic Uremic Syndrome.
    J Pediatr Hematol Oncol. 2025;47:e68-e70.
    PubMed     Abstract available
    
    
    November 2024
23. LEISTER J, Norby FL, Boucher AA
    Time to Resolution of Severe Anemia in Young Children With Iron Deficiency.
    J Pediatr Hematol Oncol. 2024 Nov 29. doi: 10.1097/MPH.0000000000002979.
    PubMed     Abstract available
    
    
    October 2024
24. ABDELKADER S, Shah R, Crawford D, Baker A, et al
    Haploidentical Stem Cell Transplants in Children With Sickle Cell Disease: A Single Center Real-world Experience.
    J Pediatr Hematol Oncol. 2024;46:e556-e557.
    PubMed    
    
    
    
25. RAFFA EH, Raffa L, Almadani S, Murad W, et al
    Optical Coherence Tomography Angiography of Macular Microangiopathy in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2024;46:349-355.
    PubMed     Abstract available
    
    
    September 2024
26. AGARWALA S, Kalra M, Sachdeva A, Anand K, et al
    Paroxysmal Cold Hemoglobinuria: Mild to Catastrophic-Spectrum of a Rare Hemolytic Anemia of Childhood.
    J Pediatr Hematol Oncol. 2024 Sep 25. doi: 10.1097/MPH.0000000000002953.
    PubMed     Abstract available
    
    
    August 2024
27. KAYA Z, Kirkiz Kayali S, Topuz Turkcan B, Yilmaz M, et al
    Concurrent Osteonecrosis of the Jaw and Hip in a Child With Severe Aplastic Anemia Undergoing Transplant.
    J Pediatr Hematol Oncol. 2024 Aug 22. doi: 10.1097/MPH.0000000000002945.
    PubMed     Abstract available
    
    
    
28. PRINCIPE DR, Reilly P, Dhavamani S, Rivers A, et al
    Hereditary Spherocytosis with Mitochondrial Retention, Increased Oxidative Stress, and Alterations to Bioactive Membrane Lipids.
    J Pediatr Hematol Oncol. 2024;46:e457-e462.
    PubMed     Abstract available
    
    
    
29. SARI TT, Wahidiyat PA, Rahmartani LD, Iskandar SD, et al
    Comparison of Yearly Cost Related to Complications Between Deferasirox and Deferiprone Monotherapy in Thalassemia.
    J Pediatr Hematol Oncol. 2024;46:e402-e405.
    PubMed     Abstract available
    
    
    
30. AL NUAIMI M, Al Khaaldi A, Trad O, Almulla A, et al
    HHV6-Associated Hydrocephalus in a Pediatric Hematopoietic Stem Cell Transplant Recipient: An Unusual Presentation.
    J Pediatr Hematol Oncol. 2024;46:e426-e429.
    PubMed     Abstract available
    
    
    July 2024
31. SINGH PP, Arora S, Danewa A, Chakraborty S, et al
    A Rare Case of Hemolysis Following Antithymocyte Globulin in a Pediatric Patient With Aplastic Anemia Receiving Immunosuppressive Therapy.
    J Pediatr Hematol Oncol. 2024 Jul 3. doi: 10.1097/MPH.0000000000002902.
    PubMed    
    
    
    
32. SELVANATHAN A, Teo J, Parayil Sankaran B
    Hematologic Manifestations in Primary Mitochondrial Diseases.
    J Pediatr Hematol Oncol. 2024;46:e338-e347.
    PubMed     Abstract available
    
    
    
33. AL-ASMARI B, Baothman A, Almohammadi M, Aljuaid M, et al
    Prevalence of Red Blood Cell Alloimmunization Among Pediatric Patients With Sickle Cell Disease in Saudi Arabia.
    J Pediatr Hematol Oncol. 2024;46:e284-e289.
    PubMed     Abstract available
    
    
    
34. SHOOK LM, Rosen BL, Mara CA, Mosley C, et al
    Attitudes, Beliefs, and Intention to Receive a COVID-19 Vaccine for Pediatric Patients With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2024;46:e305-e312.
    PubMed     Abstract available
    
    
    
35. CHAOUCH L, Moumni I, Ben Abdallah J, Bouchahda R, et al
    New Born Screening of Hemoglobinopathies in a Center Tunisian Population.
    J Pediatr Hematol Oncol. 2024;46:e296-e299.
    PubMed     Abstract available
    
    
    
36. SANCHEZ LM, Morrone K, Frei-Jones M, Fasipe TA, et al
    Clinical Practice Patterns in Sickle Cell Disease Treatment: Disease-modifying and Potentially Curative Therapies.
    J Pediatr Hematol Oncol. 2024;46:e277-e283.
    PubMed     Abstract available
    
    
    
37. HARRIS EM, Oni MO, Donado C, Heeney MM, et al
    The Risk of Kidney Injury in Patients With Sickle Cell Disease Treated With Ketorolac for Acute Pain.
    J Pediatr Hematol Oncol. 2024;46:e290-e295.
    PubMed     Abstract available
    
    
    June 2024
38. AYDIN S, Cevizoglu M
    Drug-induced Hemolytic Anemia: Isotretinoin.
    J Pediatr Hematol Oncol. 2024 Jun 26. doi: 10.1097/MPH.0000000000002912.
    PubMed    
    
    
    
39. CHEN H, Ma J, Ouyang J, Fu L, et al
    The Differences of Serum Thrombopoietin Levels Between Acquired Aplastic Anemia and Immune Thrombocytopenia in Pediatric Patients.
    J Pediatr Hematol Oncol. 2024 Jun 10. doi: 10.1097/MPH.0000000000002873.
    PubMed     Abstract available
    
    
    May 2024
40. SHARATHKUMAR A, Carr J, Claassen D, Syrbu S, et al
    Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic Syndrome.
    J Pediatr Hematol Oncol. 2024 May 24. doi: 10.1097/MPH.0000000000002891.
    PubMed     Abstract available
    
    
    
41. YURAN N, Ben-Ami T, Kori M
    Severe Unexplained Iron Deficiency Anemia in Children: High Yield of Upper Gastrointestinal Endoscopy Regardless of Gastrointestinal Symptoms.
    J Pediatr Hematol Oncol. 2024 May 13. doi: 10.1097/MPH.0000000000002863.
    PubMed     Abstract available
    
    
    
42. CREGO N, Douglas C, Bonnabeau E, Eason K, et al
    Opioid Use Among Children and Adults With Sickle Cell Disease in North Carolina Medicaid Enrollees in the Era of Opioid Harm Reduction.
    J Pediatr Hematol Oncol. 2024;46:181-187.
    PubMed     Abstract available
    
    
    April 2024
43. 
    Evaluation of Intestinal Microbiota in Children With Sickle Cell Disease: Erratum.
    J Pediatr Hematol Oncol. 2024;46:179.
    PubMed    
    
    
    
44. SHEIKH IN, Okeleji O, Afzal R, Bonfante E, et al
    Recurrent Nontraumatic Subgaleal Hematomas in a Pediatric Patient With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2024;46:e223-e226.
    PubMed     Abstract available
    
    
    
45. ABRAMSON Z, Rabe D, Persaud Y
    Pulmonary Microvascular Occlusion in Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2024;46:e212-e213.
    PubMed    
    
    
    March 2024
46. ARONSON PL, Nolan SA, Schaeffer P, Hieftje KD, et al
    Perspectives of Adolescents and Young Adults With Sickle Cell Disease and Clinicians on Improving Transition Readiness With a Video Game Intervention.
    J Pediatr Hematol Oncol. 2024;46:e147-e155.
    PubMed     Abstract available
    
    
    
47. DAUNGSUPAWONG H, Wiwanitkit V
    Barriers to Human Papilloma Virus Vaccination for Patients With Sickle Cell Disease and Childhood Cancer Survivors: Comment.
    J Pediatr Hematol Oncol. 2024;46:112-113.
    PubMed    
    
    
    February 2024
48. FRAGA C, Losa A, Cascais I, Garrido C, et al
    Severe Hemolytic Anemia: Atypical Presentation of Cobalamin Deficiency.
    J Pediatr Hematol Oncol. 2024 Feb 15. doi: 10.1097/MPH.0000000000002829.
    PubMed     Abstract available
    
    
    January 2024
49. PRIOR D, Sowa A, Pashankar F
    Normal Erythroid Precursors in Diamond-Blackfan Anemia: A Rare Case Highlighting Challenges That Remain.
    J Pediatr Hematol Oncol. 2024 Jan 25. doi: 10.1097/MPH.0000000000002820.
    PubMed     Abstract available
    
    
    
50. HIRSCHMAN L, Munchel A
    Case of Hemolytic Disease of the Fetus and Newborn Treated Without Blood Products.
    J Pediatr Hematol Oncol. 2024;46:e118-e120.
    PubMed     Abstract available
    
    
    
51. PAUL S, Nirmal G, Chadha V, Sharma R, et al
    Sirolimus-induced Hypertriglyceridemia Leads to Acute Pancreatitis and Diabetic Ketoacidosis Post Stem Cell Transplant for Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2024;46:e91-e93.
    PubMed     Abstract available
    
    
    
52. PRAMANIK-JONSSON L, Borssen M, Vonlanthen S, Nilsson F, et al
    Severe Thrombocytopenia Due to Bone Marrow Failure in Children With Dyskeratosis Congenita Does Not Respond to Eltrombopag Treatment: Case Series.
    J Pediatr Hematol Oncol. 2024;46:57-62.
    PubMed     Abstract available
    
    
    December 2023
53. XIE Z, Li W, Chen X
    Pyrites: A Case of Severe Hemolytic Anemia.
    J Pediatr Hematol Oncol. 2023 Dec 28. doi: 10.1097/MPH.0000000000002806.
    PubMed    
    
    
    November 2023
54. ZIEG J, Flachsova E, Linhartova E, Konopasek P, et al
    Severe Acute Kidney Injury in Children as a Rare Complication of Paroxysmal Cold Hemoglobinuria.
    J Pediatr Hematol Oncol. 2023;45:e1010-e1013.
    PubMed     Abstract available
    
    
    
55. RAHIM MQ, Jacob SA, Coven SL, Miller M, et al
    Identifying Barriers to HPV Vaccination for Patients With Sickle Cell Disease and Childhood Cancer Survivors.
    J Pediatr Hematol Oncol. 2023;45:e940-e947.
    PubMed     Abstract available
    
    
    
56. SCHMITTAU KM, Giordano L
    Epstein-Barr Virus-induced Paroxysmal Cold Hemoglobinuria in a 17-Year-old Male.
    J Pediatr Hematol Oncol. 2023;45:e1014-e1017.
    PubMed     Abstract available
    
    
    October 2023
57. KARAHAN F, Yilmaz SS, Bayrakdar F, Tezol O, et al
    Evaluation of Intestinal Microbiota in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2023;45:e904-e909.
    PubMed     Abstract available
    
    
    
58. CHOI DH, Violet PC, Majumdar S, Levine M, et al
    Red Blood Cell Vitamin C Concentration and Its Effect on Deformability in Pediatric Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2023;45:e936-e939.
    PubMed     Abstract available
    
    
    August 2023
59. GALADANCI AA, Estepp JH, Khan H, Farouk ZL, et al
    Barriers and Facilitators of Premarital Genetic Counseling for Sickle Cell Disease in Northern Nigeria.
    J Pediatr Hematol Oncol. 2023;45:e716-e722.
    PubMed     Abstract available
    
    
    
60. NOORDSTAR JJ, Hulzebos EHJ, van der Ent CK, Suijker MH, et al
    Organized Sports Activities Are Safe for Children With Sickle Cell Disease: A Pilot Intervention Study.
    J Pediatr Hematol Oncol. 2023;45:e710-e715.
    PubMed     Abstract available
    
    
    
61. PUGH C, Zeno RN, Stanek J, Gillespie M, et al
    Description of a Colocated Comprehensive Care Model for People With Sickle Cell and Comorbid Pulmonary Disease.
    J Pediatr Hematol Oncol. 2023;45:e723-e727.
    PubMed     Abstract available
    
    
    July 2023
62. RESTIVO GA, Scalzo S, Di Palermo A
    Mechanical Hemolytic Anemia Associated With Mitral Valve Repair: A Case Report With Literature Review.
    J Pediatr Hematol Oncol. 2023 Jul 26. doi: 10.1097/MPH.0000000000002734.
    PubMed     Abstract available
    
    
    
63. YAN A, Tole S, Bair L, Wagner A, et al
    Reassessing the Need for Preoperative Transfusions in Sickle Cell Disease Patients With an Elevated Baseline Hemoglobin-A Retrospective Study.
    J Pediatr Hematol Oncol. 2023;45:241-246.
    PubMed     Abstract available
    
    
    May 2023
64. PAULUKONIS ST, Snyder A, Smeltzer MP, Sutaria AN, et al
    COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia.
    J Pediatr Hematol Oncol. 2023;45:174-180.
    PubMed     Abstract available
    
    
    
65. ILONZE C, Anderson M, Stubblefield A, McNall-Knapp R, et al
    Transforming Growth Factor Beta 1 as a Potential Biomarker in Children With Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2023;45:225-226.
    PubMed    
    
    
    
66. KOSKELA-STAPLES NC, Evans C, Turner EM, Black LV, et al
    The Association Between Caregiver Coping and Youth Clinic Attendance and Health-related Quality of Life in Pediatric Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2023;45:e433-e440.
    PubMed     Abstract available
    
    
    April 2023
67. PATEL A, Winter T, Jain A
    A Rare Report of the Coexistence of Sickle Cell Disease, Neurofibromatosis Type 1, and Intracranial Hypertension in a Pediatric Patient.
    J Pediatr Hematol Oncol. 2023;45:155-158.
    PubMed     Abstract available
    
    
    
68. DUARTE M, Almeida Borges M, Kjollerstrom P, Maia R, et al
    Sickle Cell Disease Diagnosis Uncovered by Incidental Radiograph Findings.
    J Pediatr Hematol Oncol. 2023;45:151.
    PubMed    
    
    
    
69. DASDEMIR S, Kaya Z, Bento C
    Peripheral Blood Smear Findings in 2 Patients With Coexisting Thalassemia and Hereditary Spherocytosis.
    J Pediatr Hematol Oncol. 2023;45:149-150.
    PubMed    
    
    
    
70. AKCA T, Ozdemir GN, Aycicek A, Ozkaya G, et al
    Long-term Results of Splenectomy in Transfusion-dependent Thalassemia.
    J Pediatr Hematol Oncol. 2023;45:143-148.
    PubMed     Abstract available
    
    
    March 2023
71. YARNALL JN, Mertens A, Yee M, Orenstein E, et al
    Influenza Vaccination Receipt in Pediatric Patients With Cancer or Sickle Cell Disease.
    J Pediatr Hematol Oncol. 2023;45:e228-e235.
    PubMed     Abstract available
    
    
    
72. CALDERWOOD S, Sabir A, Rao L, Baker B, et al
    SARS-CoV-2 Infection Presenting as Acute Chest Syndrome in a Child With Hemoglobin SD-Los Angeles Disease: A Case Report and Review of Literature.
    J Pediatr Hematol Oncol. 2023;45:82-87.
    PubMed     Abstract available
    
    
    February 2023
73. IMASHUKU S, Suemori SI, Wakamatsu M, Okuno Y, et al
    Juvenile Hemochromatosis With Non-transfused Hemolytic Anemia Caused by a De Novo PIEZO1 Gene Mutation.
    J Pediatr Hematol Oncol. 2023 Feb 21. doi: 10.1097/MPH.0000000000002639.
    PubMed     Abstract available
    
    
    
74. FARRIS N, Benoit SW, McNinch NL, Bodas P, et al
    Urinary Biomarkers for the Assessment of Acute Kidney Injury of Pediatric Sickle Cell Anemia Patients Admitted for Severe Vaso-occlusive Crises.
    J Pediatr Hematol Oncol. 2023 Feb 20. doi: 10.1097/MPH.0000000000002642.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.